Lipton RB, Pozo-Rosich P, Blumenfeld A, Li Y, et al. Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial. Neurology 2022 Nov 17. pii: WNL.0000000000201568.
PMID: 36396451